MMP1 and head and neck cancer: Disease-free survival was analyzed on head and neck cancer samples from The Cancer Genome Atlas (TCGA), and the results revealed that patients with higher MMP1 expression exhibited significantly poorer survival than those with lower MMP1 expression (p = 0.017) (Figure 2E).